Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 3
2009 6
2010 2
2011 4
2012 2
2013 4
2014 3
2015 1
2017 1
2018 3
2019 2
2020 6
2021 7
2022 3
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group.
Katodritou E, Kastritis E, Dalampira D, Delimpasi S, Spanoudakis E, Labropoulou V, Ntanasis-Stathopoulos I, Gkioka AI, Giannakoulas N, Kanellias N, Papadopoulou T, Sevastoudi A, Michalis E, Papathanasiou M, Kotsopoulou M, Sioni A, Triantafyllou T, Daiou A, Papadatou M, Kyrtsonis MC, Pouli A, Kostopoulos I, Verrou E, Dimopoulos MA, Terpos E. Katodritou E, et al. Among authors: spanoudakis e. Am J Hematol. 2023 May;98(5):730-738. doi: 10.1002/ajh.26891. Epub 2023 Mar 16. Am J Hematol. 2023. PMID: 36869876
Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study.
Petrakis I, Kontogiorgis C, Nena E, Delimpasi S, Loutsidi NE, Spanoudakis E, Intzes S, Misidou C, Symeonidou M, Giannakoulas N, Constantinidis TC, Terpos E. Petrakis I, et al. Among authors: spanoudakis e. Cancers (Basel). 2023 Dec 14;15(24):5846. doi: 10.3390/cancers15245846. Cancers (Basel). 2023. PMID: 38136391 Free PMC article.
Apixaban reduces the risk of major and clinically relevant non-major bleeding compared to warfarin in patients with end stage renal disease; a systematic review and meta-analysis of ten studies.
Zagoridis K, Karatisidis L, Mprotsis T, Pentidou A, Bezirgianidou Z, Misidou C, Spanoudakis E. Zagoridis K, et al. Among authors: spanoudakis e. Thromb Res. 2023 Nov;231:17-24. doi: 10.1016/j.thromres.2023.09.005. Epub 2023 Sep 21. Thromb Res. 2023. PMID: 37748234
Reproductive Failure and Thrombophilia: Not Enough Evidence for a Tight Bond.
Stamou M, Intzes S, Symeonidou M, Bazntiara I, Bezirgiannidou Z, Pentidou A, Misidou C, Liapis K, Margaritis D, Kotsianidis I, Spanoudakis E. Stamou M, et al. Among authors: spanoudakis e. Acta Haematol. 2022;145(2):170-175. doi: 10.1159/000520439. Epub 2021 Dec 8. Acta Haematol. 2022. PMID: 34879375
Socioeconomic Status is Globally a Prognostic Factor for Overall Survival of Multiple Myeloma Patients: Synthesis of Studies and Review of the Literature.
Intzes S, Symeonidou M, Zagoridis K, Bezirgianidou Z, Vrachiolias G, Spanoudaki A, Spanoudakis E. Intzes S, et al. Among authors: spanoudakis e. Mediterr J Hematol Infect Dis. 2021 Jan 1;13(1):e2021006. doi: 10.4084/MJHID.2021.006. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 33489045 Free PMC article. Review.
Natural killer T cells and haemopoiesis.
Karadimitris A, Patterson S, Spanoudakis E. Karadimitris A, et al. Among authors: spanoudakis e. Br J Haematol. 2006 Aug;134(3):263-72. doi: 10.1111/j.1365-2141.2006.06187.x. Br J Haematol. 2006. PMID: 16848769 Free article. Review.
48 results